2024 Q3 Form 10-Q Financial Statement

#000129894624000095 Filed on August 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $285.1M $309.3M
YoY Change 3.11% 6.19%
Cost Of Revenue $204.6M $211.9M
YoY Change 4.19% 6.1%
Gross Profit $80.57M $97.40M
YoY Change 0.49% 6.38%
Gross Profit Margin 28.26% 31.49%
Selling, General & Admin $7.660M $28.52M
YoY Change -25.49% 244.27%
% of Gross Profit 9.51% 29.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $28.36M $27.87M
YoY Change 2.43% 0.12%
% of Gross Profit 35.19% 28.62%
Operating Expenses $36.02M $56.39M
YoY Change -5.13% 56.11%
Operating Profit $44.56M $41.01M
YoY Change 5.54% -26.02%
Interest Expense -$15.99M -$15.01M
YoY Change -200.08% -0.25%
% of Operating Profit -35.88% -36.6%
Other Income/Expense, Net -$15.99M -$15.01M
YoY Change 5.16% -0.25%
Pretax Income $26.98M $26.00M
YoY Change -2.1% -34.27%
Income Tax $418.0K $1.368M
% Of Pretax Income 1.55% 5.26%
Net Earnings $26.43M $24.53M
YoY Change -3.08% -32.81%
Net Earnings / Revenue 9.27% 7.93%
Basic Earnings Per Share $0.11 $0.10
Diluted Earnings Per Share $0.11 $0.10
COMMON SHARES
Basic Shares Outstanding 207.3M shares 210.1M shares
Diluted Shares Outstanding 210.2M shares 212.0M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $75.29M $125.2M
YoY Change -26.72% 27.05%
Cash & Equivalents $75.29M $125.2M
Short-Term Investments
Other Short-Term Assets $69.77M $74.99M
YoY Change -12.99% -13.03%
Inventory
Prepaid Expenses
Receivables $168.0M $171.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $313.0M $372.0M
YoY Change -10.72% 6.6%
LONG-TERM ASSETS
Property, Plant & Equipment $2.727B $2.735B
YoY Change -1.39% -3.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $44.49M $45.21M
YoY Change 4.68% 20.43%
Total Long-Term Assets $2.868B $2.877B
YoY Change -1.29% 0.03%
TOTAL ASSETS
Total Short-Term Assets $313.0M $372.0M
Total Long-Term Assets $2.868B $2.877B
Total Assets $3.181B $3.249B
YoY Change -2.3% 0.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $166.0M $168.6M
YoY Change -3.34% 5.68%
Accrued Expenses $114.4M $113.8M
YoY Change 2.28% 2.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $287.0M $288.4M
YoY Change -1.0% 4.05%
LONG-TERM LIABILITIES
Long-Term Debt $1.097B $1.172B
YoY Change -6.96% -0.76%
Other Long-Term Liabilities $139.2M $138.7M
YoY Change 1.94% 1.95%
Total Long-Term Liabilities $1.236B $1.311B
YoY Change -6.03% -0.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $287.0M $288.4M
Total Long-Term Liabilities $1.236B $1.311B
Total Liabilities $1.523B $1.600B
YoY Change -5.12% -0.12%
SHAREHOLDERS EQUITY
Retained Earnings -$616.9M -$633.9M
YoY Change -5.31% -5.39%
Common Stock $2.073M $2.079M
YoY Change -1.1% -99.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.649B $1.640B
YoY Change
Total Liabilities & Shareholders Equity $3.181B $3.249B
YoY Change -2.3% 0.74%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $26.43M $24.53M
YoY Change -3.08% -32.81%
Depreciation, Depletion And Amortization $28.36M $27.87M
YoY Change 2.43% 0.12%
Cash From Operating Activities $61.66M $55.72M
YoY Change -12.24% -1.13%
INVESTING ACTIVITIES
Capital Expenditures $22.63M $16.91M
YoY Change -55.99% -39.85%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$22.63M -$16.91M
YoY Change -54.67% -42.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -89.68M -33.63M
YoY Change 701.12% 154.94%
NET CHANGE
Cash From Operating Activities 61.66M 55.72M
Cash From Investing Activities -22.63M -16.91M
Cash From Financing Activities -89.68M -33.63M
Net Change In Cash -50.64M 5.180M
YoY Change -653.55% -61.77%
FREE CASH FLOW
Cash From Operating Activities $61.66M $55.72M
Capital Expenditures $22.63M $16.91M
Free Cash Flow $39.03M $38.81M
YoY Change 107.15% 37.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167171000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1595273000 usd
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
207918179 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
207918179 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1596178000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
9188000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-84000 usd
CY2023Q1 drh Oci Equity Method Investment After Tax Including Portion Attributable To Noncontrolling Interest
OCIEquityMethodInvestmentAfterTaxIncludingPortionAttributableToNoncontrollingInterest
237000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.03
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
6327000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5156
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
2454000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1967000 usd
CY2023Q1 drh Stock Redeemed To Satisfy Withholdings On Vested Share Based Compensation Value
StockRedeemedToSatisfyWithholdingsOnVestedShareBasedCompensationValue
3023000 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
409000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
39134000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
3467000 usd
CY2023Q2 drh Oci Equity Method Investment After Tax Including Portion Attributable To Noncontrolling Interest
OCIEquityMethodInvestmentAfterTaxIncludingPortionAttributableToNoncontrollingInterest
210000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.03
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
6319000 usd
CY2023Q2 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5156
CY2023Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
2454000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2760000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2014000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1630057000 usd
us-gaap Profit Loss
ProfitLoss
32989000 usd
us-gaap Profit Loss
ProfitLoss
48322000 usd
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
56186000 usd
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
55312000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
67000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
99000 usd
drh Non Cash Lease Expense And Other Amortization
NonCashLeaseExpenseAndOtherAmortization
3073000 usd
drh Non Cash Lease Expense And Other Amortization
NonCashLeaseExpenseAndOtherAmortization
3087000 usd
drh Fair Value Adjustment Of Derivative Instruments
FairValueAdjustmentOfDerivativeInstruments
0 usd
drh Fair Value Adjustment Of Derivative Instruments
FairValueAdjustmentOfDerivativeInstruments
2033000 usd
drh Amortization Of Financing Costs And Derivative Gains Losses
AmortizationOfFinancingCostsAndDerivativeGainsLosses
1026000 usd
drh Amortization Of Financing Costs And Derivative Gains Losses
AmortizationOfFinancingCostsAndDerivativeGainsLosses
1026000 usd
drh Impairment Charges Included In Continuing And Discontinued Operations
ImpairmentChargesIncludedInContinuingAndDiscontinuedOperations
0 usd
drh Impairment Charges Included In Continuing And Discontinued Operations
ImpairmentChargesIncludedInContinuingAndDiscontinuedOperations
941000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
215000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
215000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
9862000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4727000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2266000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5940000 usd
drh Increase Decrease In Due To From Hotel Managers
IncreaseDecreaseInDueToFromHotelManagers
11942000 usd
drh Increase Decrease In Due To From Hotel Managers
IncreaseDecreaseInDueToFromHotelManagers
-8540000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1827000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3508000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
86953000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
114424000 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
35778000 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
47928000 usd
us-gaap Payments To Acquire Land
PaymentsToAcquireLand
0 usd
us-gaap Payments To Acquire Land
PaymentsToAcquireLand
1829000 usd
drh Payments For Purchase Deposits
PaymentsForPurchaseDeposits
0 usd
drh Payments For Purchase Deposits
PaymentsForPurchaseDeposits
1500000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35778000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51257000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
4905000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
4744000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12861000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
19156000 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
4908000 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
4908000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20610000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2423000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4638000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3023000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-47922000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34254000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3253000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
28913000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107178000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170424000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136091000 usd
us-gaap Interest Paid Net
InterestPaidNet
31605000 usd
us-gaap Interest Paid Net
InterestPaidNet
29314000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2351000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1833000 usd
drh Unpaid Dividends And Distributions Declared
UnpaidDividendsAndDistributionsDeclared
6067000 usd
drh Unpaid Dividends And Distributions Declared
UnpaidDividendsAndDistributionsDeclared
6437000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4043000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6153000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125219000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121595000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
45205000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
45576000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170424000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167171000 usd
CY2024Q2 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
36 hotel
CY2024Q2 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
9760 room
CY2024Q2 drh Number Of Hotels Operated Percentage
NumberOfHotelsOperatedPercentage
0.60
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4095139000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4059985000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1360513000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1304790000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2734626000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2755195000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4000000.0 usd
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4700000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
1173285000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
1178189000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
1172479000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
1177005000 usd
CY2024Q2 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0522
CY2024Q2 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
36 hotel
CY2024Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
513000 usd
CY2023Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
512000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1026000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1026000 usd
CY2024Q2 drh Interest Expense Income Trading Liabilities
InterestExpenseIncomeTradingLiabilities
0 usd
CY2023Q2 drh Interest Expense Income Trading Liabilities
InterestExpenseIncomeTradingLiabilities
19000 usd
drh Interest Expense Income Trading Liabilities
InterestExpenseIncomeTradingLiabilities
0 usd
drh Interest Expense Income Trading Liabilities
InterestExpenseIncomeTradingLiabilities
2033000 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
16202000 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
15567000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
32448000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
32739000 usd
us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
2300000 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
drh Common Stock Voting Rights Votes
CommonStockVotingRightsVotes
1 vote
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 drh Common Unit Issuance Value Per Share
CommonUnitIssuanceValuePerShare
11.76
CY2018Q4 drh Operating Partnership Units Option To Redeem For Common Stock Ratio
OperatingPartnershipUnitsOptionToRedeemForCommonStockRatio
1
CY2018Q4 drh Operating Partnership Units Option To Redeem For Common Stock Ratio
OperatingPartnershipUnitsOptionToRedeemForCommonStockRatio
1
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.06
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.06
us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
1.0313
us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
1.0313
drh Share Based Compensation Arrangement By Share Based Payment Award Conversion Ratio
ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRatio
1
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22076000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36511000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
27950000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
43213000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211195463 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211673828 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211432403 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211543398 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212016445 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212161950 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212276815 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212092590 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001298946-24-000095-index-headers.html Edgar Link pending
0001298946-24-000095-index.html Edgar Link pending
0001298946-24-000095.txt Edgar Link pending
0001298946-24-000095-xbrl.zip Edgar Link pending
a102jeffreyjdonnellysevera.htm Edgar Link pending
a103justinlleonardseveranc.htm Edgar Link pending
a104brionyrquinnseverancea.htm Edgar Link pending
a108anikafischerseverancea.htm Edgar Link pending
drh-20240630.htm Edgar Link pending
drh-20240630.xsd Edgar Link pending
drh_exhibit311xjune302024.htm Edgar Link pending
drh_exhibit312xjune302024.htm Edgar Link pending
drh_exhibit321xjune302024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
drh-20240630_def.xml Edgar Link unprocessable
drh-20240630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
drh-20240630_pre.xml Edgar Link unprocessable
drh-20240630_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
drh-20240630_cal.xml Edgar Link unprocessable